Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-02

Clinical Trial Update: Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing conventional step-up therapy to infliximab monotherapy for ulcerative colitis was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Colitis, Ulcerative | Phase 3 | Status: TERMINATED | Results posted: 2013-04-02